Announcements Trials
Browse Landscape

Phase

Phase 4 2

Status

Completed 9Not yet recruiting 5Unknown 4Recruiting 3Withdrawn 2Terminated 1Active not recruiting 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Classical hematology 4Other hematologic neoplasm 2Lymphoid 1

Conditions

Leukemia, Myeloid, Acute 140Leukemia 97Leukemia, Lymphocytic, Chronic, B-Cell 96Precursor Cell Lymphoblastic Leukemia-Lymphoma 90Hematologic Neoplasms 69Myelodysplastic Syndromes 55Lymphoma 47Lymphoma, Non-Hodgkin 45Lymphoma, B-Cell, Marginal Zone 34Leukemia, Myelogenous, Chronic, BCR-ABL Positive 34Lymphoma, Mantle-Cell 33Lymphoma, Follicular 33Burkitt Lymphoma 32Recurrence 28Lymphoma, Large B-Cell, Diffuse 28Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 24Hodgkin Disease 23Neoplasms 22Leukemia, Myelomonocytic, Chronic 22Multiple Myeloma 21Myeloproliferative Disorders 20Waldenstrom Macroglobulinemia 19Lymphoma, Large-Cell, Immunoblastic 19Leukemia, Myeloid, Chronic-Phase 17Congenital Abnormalities 16Primary Myelofibrosis 15Leukemia, Myeloid, Accelerated Phase 14Leukemia, Biphenotypic, Acute 14Mycosis Fungoides 13Lymphoma, T-Cell, Cutaneous 13

Interventions

ceftolozane, tazobactam drug combination 1Micafungin 1Meropenem 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Withdrawn × Febrile Neutropenia × Other hematologic neoplasm × Clear all
NCT05784844 2024-09-19

Antimicrobial Revision in Persistent Febrile Neutropenia

Wake Forest University Health Sciences

Phase 4 Withdrawn
Classical hematologyLymphoidOther hematologic neoplasm

Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Febrile Neutropenia

NCT05061654 2023-08-14

CEF-10

Hamad Medical Corporation

Phase 4 Withdrawn
Classical hematologyOther hematologic neoplasm

Hematologic Neoplasms, Febrile Neutropenia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡